These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30985672)

  • 1. Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study.
    Ruscitti P; Cipriani P; Liakouli V; Guggino G; Carubbi F; Berardicurti O; Ciccia F; Giacomelli R
    Medicine (Baltimore); 2019 Apr; 98(15):e15123. PubMed ID: 30985672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
    Kalyoncu U; Solmaz D; Emmungil H; Yazici A; Kasifoglu T; Kimyon G; Balkarli A; Bes C; Ozmen M; Alibaz-Oner F; Erten S; Cagatay Y; Cetin GY; Yilmaz S; Yildiz F; Pamuk ON; Kucuksahin O; Kilic L; Yazisiz V; Karadag O; Koca SS; Hayran M; Akar S; Aksu K; Akkoc N; Keser G; Gonullu E; Kisacik B; Onat AM; Soy M; Inanc N; Direskeneli H; Sayarlioglu M; Erken E; Turgay M; Cefle A; Ertenli I; Pay S
    J Autoimmun; 2016 May; 69():59-63. PubMed ID: 26970681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
    Ruscitti P; Cipriani P; Liakouli V; Iacono D; Pantano I; Caso F; Perosa F; Atzeni F; Cantatore FP; Scarpa R; Ciccia F; Giacomelli R
    Rheumatol Int; 2020 Jan; 40(1):107-113. PubMed ID: 31263993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset Still's disease: clinical, serological and therapeutic considerations.
    Iliou C; Papagoras C; Tsifetaki N; Voulgari PV; Drosos AA
    Clin Exp Rheumatol; 2013; 31(1):47-52. PubMed ID: 23010097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry.
    Ruscitti P; Sota J; Vitale A; Lopalco G; Iannone F; Morrone M; Giardini HAM; D'Agostin MA; Antonelli IPB; Almaghlouth I; Asfina KN; Khalil N; Sfikakis PP; Laskari K; Tektonidou M; Ciccia F; Iacono D; Riccio F; Ragab G; Hussein MA; Govoni M; Ruffilli F; Direskeneli H; Alibaz-Oner F; Giacomelli R; Navarini L; Bartoloni E; Riccucci I; Martín-Nares E; Torres-Ruiz J; Cipriani P; Di Cola I; Hernández-Rodríguez J; Gómez-Caverzaschi V; Dagna L; Tomelleri A; Makowska J; Brzezinska O; Iagnocco A; Bellis E; Caggiano V; Gaggiano C; Tarsia M; Mormile I; Emmi G; Sfriso P; Monti S; Erten Ş; Del Giudice E; Lubrano R; Conti G; Olivieri AN; Lo Gullo A; Tharwat S; Karamanakos A; Gidaro A; Maggio MC; La Torre F; Cardinale F; Ogunjimi B; Maier A; Sebastiani GD; Opris-Belinski D; Frassi M; Viapiana O; Bizzi E; Carubbi F; Fotis L; Tufan A; Kardas RC; Więsik-Szewczyk E; Jahnz-Różyk K; Fabiani C; Frediani B; Balistreri A; Rigante D; Cantarini L
    Semin Arthritis Rheum; 2023 Oct; 62():152244. PubMed ID: 37517110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review on adult onset Still's disease.
    Giacomelli R; Ruscitti P; Shoenfeld Y
    J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies.
    Ruscitti P; Ursini F; Cipriani P; De Sarro G; Giacomelli R
    Expert Rev Clin Immunol; 2017 Nov; 13(11):1089-1097. PubMed ID: 28870100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
    Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
    J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-filtration plasmapheresis for resolution of corticosteroid resistant adult onset Still's disease.
    Kato T; Kobayashi T; Nishino H; Hidaka Y
    Clin Rheumatol; 2006 Jul; 25(4):579-82. PubMed ID: 16568213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution and prognosis of adult onset Still's disease. A monocentric study of 17 patients].
    Fraisse TC; Degraeve F; Rivière S; Le Quellec A
    Rev Med Interne; 2006 Sep; 27(9):658-64. PubMed ID: 16750873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult onset Still's disease: experience from a tertiary care rheumatology unit.
    Reddy Munagala VV; Misra R; Agarwal V; Lawrence A; Aggarwal A
    Int J Rheum Dis; 2012 Dec; 15(6):e136-41. PubMed ID: 23253241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
    Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
    Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases.
    Nakamura H; Odani T; Shimizu Y; Takeda T; Kikuchi H
    Mod Rheumatol; 2016 Nov; 26(6):963-967. PubMed ID: 25036233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and prognosis in 82 patients with adult-onset Still's disease.
    Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
    Clin Exp Rheumatol; 2014; 32(1):28-33. PubMed ID: 24050706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease.
    Franchini S; Dagna L; Salvo F; Aiello P; Baldissera E; Sabbadini MG
    Arthritis Rheum; 2010 Aug; 62(8):2530-5. PubMed ID: 20506370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China.
    Hu QY; Zeng T; Sun CY; Luo CN; Liu S; Ding TT; Ji ZF; Lu A; Yimaiti K; Teng JL; Cheng XB; Ye JN; Su YT; Shi H; Sun Y; Chi HH; Zhou ZC; Chen LJ; Xu J; Jiang LD; Wu LJ; Lin J; Yang CD; Liu HL
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):52-57. PubMed ID: 31573475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose methotrexate treatment in adult Still's disease.
    Aydintug AO; D'Cruz D; Cervera R; Khamashta MA; Hughes GR
    J Rheumatol; 1992 Mar; 19(3):431-5. PubMed ID: 1578459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Adolescent-onset Still's disease": characteristics and outcome in comparison with adult-onset Still's disease.
    Luthi F; Zufferey P; Hofer MF; So AK
    Clin Exp Rheumatol; 2002; 20(3):427-30. PubMed ID: 12102485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease.
    Kiyonaga Y; Maeshima K; Imada C; Haranaka M; Ishii K; Shibata H
    Intern Med; 2014; 53(11):1209-13. PubMed ID: 24881751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.
    Kadavath S; Zapantis E; Zolty R; Efthimiou P
    Int J Rheum Dis; 2014 Mar; 17(3):336-40. PubMed ID: 24581387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.